Issue 4/2008
Content (10 Articles)
A Benefit-Risk Review of Systemic Haemostatic Agents
Ian S. Fraser, Robert J Porte, Peter A. Kouides, Andrea S. Lukes
Adequacy of Patient Information on Adverse Effects
Neil Carrigan, D. K. Raynor, Peter Knapp
Safety Profile of Esomeprazole
Miranda Davies, Lynda V. Wilton, Saad A. W. Shakir
Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease
Andrew L. Avins, Michele M. Manos, Lynn Ackerson, Wei Zhao, Rosemary Murphy, Theodore R. Levin, Douglas J. Watson, Peggy M. T. Hwang, Amy Replogle, Jeffrey G. Levine
Improving the Reporting of Adverse Drug Reactions
Maria T. Herdeiro, Jorge Polónia, Juan J. Gestal-Otero, Adolfo Figueiras
Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder
Mark E. Bangs, Ling Jin, Shuyu Zhang, Durisala Desaiah, Albert J. Allen, Holly A. Read, Arie Regev, Joachim F. Wernicke
Publishing Histories of Adverse Reactions to Medicaments Anecdotally
Jeffrey K. Aronson
The Authors’ Reply
William Kelly, Nicholas Moore, David I. Goldsmith, Judith K. Jones, Thierry Trenque, Eugene van Puijenbroek